Adoption of the American Academy of Pediatrics' neonatal hyperbilirubinemia guidelines and its effect on blood exchange transfusion rate in a tertiary care center in Amman, Jordan
- PMID: 29713209
- PMCID: PMC5908209
- DOI: 10.2147/JBM.S162191
Adoption of the American Academy of Pediatrics' neonatal hyperbilirubinemia guidelines and its effect on blood exchange transfusion rate in a tertiary care center in Amman, Jordan
Abstract
Introduction: Severe neonatal hyperbilirubinemia can cause mortality and serious morbidities. When phototherapy fails, neonates with severe hyperbilirubinemia should undergo double volume blood exchange transfusion (BET). As this procedure carries a significant risk of mortality and morbidity, adopting guidelines for the treatment of neonatal hyperbilirubinemia is critical to avoid hyperbilirubinemia toxicity and also the complication of an unindicated procedure.
Methods: This study investigated the causes, complications, and trend of BET rate in our unit over a 13-year period. The medical charts and laboratory databases of all infants who underwent BET in Jordan University Hospital between 2003 and 2015 were retrospectively reviewed.
Results: The rate of exchange cases decreased significantly after adopting the guidelines of American Academy of Pediatrics (P<0.0001). Most neonates were term newborns (69%). Average birth weight was 2,800 g. The most common causes of exchange transfusion were non-hemolytic conditions. Late prematurity alone accounted for 20% of the cases. Thrombocytopenia was the most commonly encountered complication (33%). Chronic neurological complications were seen in 12% of those who were followed for >12 months of age.
Conclusions: This study showed a clear decline in the rate of BET after implementing the guidelines of American Academy of Pediatrics. In addition to improving the strategies for the identification and follow-up of at-risk newborns, we should intensify our efforts to prevent the progression of neonatal hyperbilirubinemia to the exchange level by enhancing parents' awareness of this potentially harmful neonatal condition.
Keywords: Jordan; exchange transfusion; guidelines; hyperbilirubinemia; neonate.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.Pediatrics. 2001 Dec;108(6):1374-7. doi: 10.1542/peds.108.6.1374. Pediatrics. 2001. PMID: 11731664
-
Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates.Cochrane Database Syst Rev. 2021 Jul 6;7(7):CD013277. doi: 10.1002/14651858.CD013277.pub2. Cochrane Database Syst Rev. 2021. PMID: 34228352 Free PMC article.
-
Effect of publication of the "Practice Parameter for the management of hyperbilirubinemia" on treatment of neonatal jaundice.Acta Paediatr. 2001 Mar;90(3):292-5. Acta Paediatr. 2001. PMID: 11332170
-
Exchange transfusion for neonatal hyperbilirubinemia: an 8-year single center experience at a tertiary neonatal intensive care unit in Turkey.J Matern Fetal Neonatal Med. 2015 Sep;28(13):1537-41. doi: 10.3109/14767058.2014.960832. Epub 2014 Sep 22. J Matern Fetal Neonatal Med. 2015. PMID: 25182682
-
Jaundice in the newborn.Indian J Pediatr. 2001 Oct;68(10):977-80. doi: 10.1007/BF02722600. Indian J Pediatr. 2001. PMID: 11758137 Review.
Cited by
-
Exchange transfusions in severe Rh-mediated alloimmune haemolytic disease of the foetus and newborn: a 20-year overview on the incidence, associated risks and outcome.Vox Sang. 2021 Oct;116(9):990-997. doi: 10.1111/vox.13090. Epub 2021 Mar 17. Vox Sang. 2021. PMID: 33730387 Free PMC article.
-
Exchange Transfusion Trends and Risk Factors for Extreme Neonatal Hyperbilirubinemia over 10 Years in Shiraz, Iran.Iran J Med Sci. 2024 Jun 1;49(6):384-393. doi: 10.30476/ijms.2023.99176.3123. eCollection 2024 Jun. Iran J Med Sci. 2024. PMID: 38952637 Free PMC article.
-
Exchange Transfusion in Neonatal Sepsis: A Narrative Literature Review of Pros and Cons.J Clin Med. 2022 Feb 24;11(5):1240. doi: 10.3390/jcm11051240. J Clin Med. 2022. PMID: 35268331 Free PMC article. Review.
-
Study on the Effect of Two Different Transfusion Methods in Neonates with Hyperbilirubinemia Induced by Non-Blood-Group Antibodies.Int J Gen Med. 2021 Oct 28;14:7311-7316. doi: 10.2147/IJGM.S338874. eCollection 2021. Int J Gen Med. 2021. PMID: 34737625 Free PMC article.
References
-
- Bhutani VK, Stark AR, Lazzeroni LC, et al. Initial Clinical Testing Evaluation and Risk Assessment for Universal Screening for Hyperbilirubinemia Study Group Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr. 2013;162(3):477.e1–482.e1. - PubMed
-
- American Academy of Pediatrics Subcommittee on Hyperbilirubinemia Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316. - PubMed
-
- Abu-Ekteish F, Daoud A, Rimawi H, Kakish K, Abu-Heija A. Neonatal exchange transfusion: a Jordanian experience. Ann Trop Paediatr. 2000;20(1):57–60. - PubMed
-
- Jangaard KA, Allen A. Changes in practice patterns for treatment of hyperbilirubinemia in healthy, full term infants in Nova Scotia, Canada following the AAP practice parameters. Paediatr Child Health. 2002;7(Suppl A):22A–23A.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials